Doximity has acquired Montreal-based Pathway Medical Inc., a startup specialising in medical AI and clinical reference.
Half of Pathway’s team are physicians, and over seven years, they have built one of the largest AI-ready datasets covering major medical guidelines, drugs, and trials. Pathway’s model recently achieved 96% accuracy on the USMLE benchmark.
The acquisition was finalized for $26 million in cash plus up to $37 million in equity grants.
KEY QUOTES:
“We’re thrilled to welcome the Pathway team to Doximity. They’ve painstakingly built one of the best datasets in medicine, and it’s going to take our clinical reference capabilities to an entirely new level.”
Jeff Tangney, co-founder and CEO of Doximity
“There’s a growing need for clinical tools that combine trusted evidence with the speed and adaptability of AI. Hundreds of thousands of users have registered for Pathway, and thousands pay $300 per year for our premium product. With Doximity, one of the most trusted platforms in healthcare, we’re now bringing that experience to millions for free, built directly into the tools they already use at the point of care.”
Jon Hershon, CEO of Pathway
